• Home
  • Norgine And Arc Medical Announce Partnership For Endoscopic Device, ENDOCUFF VISION™

Norgine And Arc Medical Announce Partnership For Endoscopic Device, ENDOCUFF VISION™

LONDON, UK, 12 March 2015, 07.00 GMT – Norgine and Arc Medical Design Ltd. today announced a partnership that will see Norgine commercialising and distributing ENDOCUFF VISION™, a Class 1 sterile medical device used in colonoscopy, across a number of major European markets, Australia and New Zealand. Norgine’s first launch of ENDOCUFF VISION™ will take place in the UK Q2 2015.

ENDOCUFF VISION™ is a single use, sterile endoscopic overtube, which fits onto the distal end of most endoscopes, and has been designed to improve tip control during extubation and enhance mucosal vision in patients with diseases of the colon, including colorectal cancer. The improved visualisation of lesions has been shown to result in an increase in both the Adenoma Detection Rate (ADR) and Mean Adenomas per Patient (MAP) rate.

Colorectal cancer is the second most common cause of cancer-related mortality in the world[5]; nearly 1.4 million new cases of colorectal cancer were diagnosed worldwide in 2012 and 412,000 people are diagnosed with it every year in Europe.[6], [7] The detection and removal of adenomas during colonoscopy substantially reduces both the development of and death from colorectal cancer.[8] In the UK alone, diagnosis at the earliest stage is associated with a 93.2% five-year survival rate, compared with a 6.6% five-year survival rate for diagnosis of metastatic colorectal cancer.[9]

Peter Stein, Chief Executive Officer Norgine, commented, “We are excited about our new partnership with Arc Medical and the promotion of ENDOCUFF VISION™, a device which not only leads to a significant increase in lesion detection, but also ensures a quality colonoscopy and avoids the need for repeat procedures - thus significantly improving the patient experience. This partnership is a further example of Norgine’s commitment to improving quality in colonoscopy and adds to our existing bowel cleansing portfolio.”

 “We are delighted to work in partnership with Norgine to expand the number of markets where ENDOCUFF VISION™ is available,” said Tas Javed, Managing Director, Arc Medical. “We strive to turn innovative ideas into successful products that fill an unmet need in medical design, ultimately improving health outcomes and patient quality of life.”


" The Endocuff is feasible, safe, reliable and easy to handle and might have potential to reduce the incidence of colorectal cancer "

Dr Meister, Clinical Endocrirology News Digital Network

" ...potential to become an indispensable tool of every colon cancer surveillance program "

Dr Meister, UEGW 2014

" My colleagues and I have definitely found polyps that they didn’t see with the forward view. We feel we were doing an excellent exam with current colonoscopy and that this made it better. "

Outpatient Surgery Magazine



© 2017
ARC Medical Design Ltd

Site Map


Sign up for all the latest news and information about our innovative colonoscopy products

Arc Medical Design Ltd | 43 Park Place, Leeds, LS1 2RY | Registered in England No: 06717387